Anti-TNF Treatment In Refractory Sarcoidosis; Therapeutic Impacts Of Adalimumab And Infliximab. The Review of Diabetic Studies , [S. l.], p. 120–130, 2025. DOI: 10.70082/crmrkr78. Disponível em: https://www.diabeticstudies.org/index.php/RDS/article/view/656. Acesso em: 29 oct. 2025.